WHO Statement on Public Disclosure of Clinical Trial Results: A welcomed commitment on transparency but one that should capitalise on best practices

The International Society of Drug Bulletins (ISDB), Medicines in Europe Forum (MiEF), Health Action International (HAI) Europe, Nordic Cochrane Centre (NCC) and Public Citizen submitted this joint response to the WHO public consultation on public disclosure of clinical trial results. 

Attachment: en_jointresponse_who_statement_public_disclosure_ctresults.pdf